Compound ID | 89
S201
Class: Beta-lactam (cephalosporin)
| Spectrum of activity: | Gram-negative |
| Details of activity: | E.coli and K.pneumonia, possible broad spectrum application |
| Combined with other compounds: | Yes |
| Institute where first reported: | Sopharmia Inc, USA |
| Year first mentioned: | 2014 |
| Highest developmental phase: | Preclinical |
| Development status: | Experimental |
| External links: | |
| Citation: | http://gladiuspharma.com/ |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.